# Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis

> **NCT06811558** · NA · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 100 (estimated)

## Conditions studied

- Over 70-year-old Patients with Psoriasis

## Interventions

- **BIOLOGICAL:** Ixekizumab
- **BIOLOGICAL:** Secukizumab

## Key facts

- **NCT ID:** NCT06811558
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06811558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06811558, "Ixekizumab Versus Secukizumab in Over 70-year-old Patients with Psoriasis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06811558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*